Jessica A Alvarez1, Thomas R Ziegler2, Erin C Millson3, Arlene A Stecenko4. 1. Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA; Center for Clinical and Molecular Nutrition, Emory University School of Medicine, Atlanta, Georgia, USA; Center for Cystic Fibrosis and Airways Disease Research, Children's Healthcare of Atlanta, Atlanta, Georgia, USA. Electronic address: jessica.alvarez@emory.edu. 2. Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA; Center for Clinical and Molecular Nutrition, Emory University School of Medicine, Atlanta, Georgia, USA; Center for Cystic Fibrosis and Airways Disease Research, Children's Healthcare of Atlanta, Atlanta, Georgia, USA. 3. Center for Clinical and Molecular Nutrition, Emory University School of Medicine, Atlanta, Georgia, USA; Clinical Research Network, Atlanta Clinical and Translational Science Institute, Atlanta, Georgia, USA. 4. Center for Cystic Fibrosis and Airways Disease Research, Children's Healthcare of Atlanta, Atlanta, Georgia, USA; Division of Pulmonology, Allergy/Immunology, Cystic Fibrosis and Sleep, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Abstract
OBJECTIVES: This study aimed to evaluate the relationship between lung function and body composition in cystic fibrosis (CF) and examine the presence of normal-weight obesity (NWO), a high body fat percentage with a normal body mass index (BMI), in this population. METHODS: In a pilot, cross-sectional study, 32 subjects with CF and a reference group of 20 adults without CF underwent body composition analysis with air displacement plethysmography. NWO was defined as a BMI <25 kg/m(2) and body fat >30% (for women) or >23% (for men). Lung function in subjects with CF was determined by the percentage of predicted forced expiratory volume in 1 s (FEV1% predicted). RESULTS: Despite lower BMI and fat-free mass index (P < 0.01), fat mass index and percent body fat did not differ between subjects with CF and the reference group. Among subjects with CF, FEV1% predicted was positively associated with fat-free mass index (β = 6.31 ± 2.93, P = 0.04) and inversely associated with fat mass index (β = -6.44 ± 2.93, P = 0.04), after adjusting for age, sex, and BMI. Ten subjects with CF (31%) had NWO, which corresponded with lower fat-free mass index and FEV1% predicted compared with overweight subjects (P = 0.006 and 0.004, respectively). CONCLUSIONS: Excess adiposity, particularly in the form of NWO, was inversely associated with lung function in CF. Larger prospective studies should be undertaken to confirm these findings and determine the long-term metabolic and clinical consequences of excess adiposity in CF. As the lifespan of individuals with CF increases, nutrition screening protocols, which primarily rely on BMI, may require reassessment.
OBJECTIVES: This study aimed to evaluate the relationship between lung function and body composition in cystic fibrosis (CF) and examine the presence of normal-weight obesity (NWO), a high body fat percentage with a normal body mass index (BMI), in this population. METHODS: In a pilot, cross-sectional study, 32 subjects with CF and a reference group of 20 adults without CF underwent body composition analysis with air displacement plethysmography. NWO was defined as a BMI <25 kg/m(2) and body fat >30% (for women) or >23% (for men). Lung function in subjects with CF was determined by the percentage of predicted forced expiratory volume in 1 s (FEV1% predicted). RESULTS: Despite lower BMI and fat-free mass index (P < 0.01), fat mass index and percent body fat did not differ between subjects with CF and the reference group. Among subjects with CF, FEV1% predicted was positively associated with fat-free mass index (β = 6.31 ± 2.93, P = 0.04) and inversely associated with fat mass index (β = -6.44 ± 2.93, P = 0.04), after adjusting for age, sex, and BMI. Ten subjects with CF (31%) had NWO, which corresponded with lower fat-free mass index and FEV1% predicted compared with overweight subjects (P = 0.006 and 0.004, respectively). CONCLUSIONS: Excess adiposity, particularly in the form of NWO, was inversely associated with lung function in CF. Larger prospective studies should be undertaken to confirm these findings and determine the long-term metabolic and clinical consequences of excess adiposity in CF. As the lifespan of individuals with CF increases, nutrition screening protocols, which primarily rely on BMI, may require reassessment.
Authors: Alina A Ionescu; William D Evans; Rebecca J Pettit; Lisette S Nixon; Michael D Stone; Dennis J Shale Journal: Chest Date: 2003-12 Impact factor: 9.410
Authors: Ankitha Madde; William Okoniewski; Don B Sanders; Clement L Ren; Daniel J Weiner; Erick Forno Journal: J Cyst Fibros Date: 2021-12-28 Impact factor: 5.527
Authors: Moriah P Bellissimo; Ivana Zhang; Elizabeth A Ivie; Phong H Tran; Vin Tangpricha; William R Hunt; Arlene A Stecenko; Thomas R Ziegler; Jessica A Alvarez Journal: J Cyst Fibros Date: 2019-01-18 Impact factor: 5.482
Authors: Katharina Staufer; Emina Halilbasic; Peter Hillebrand; Solveig Harm; Stefan Schwarz; Peter Jaksch; Danijel Kivaranovic; Walter Klepetko; Michael Trauner; Lili Kazemi-Shirazi Journal: United European Gastroenterol J Date: 2018-05-17 Impact factor: 4.623
Authors: Catherine M McDonald; Jessica A Alvarez; Julianna Bailey; Ellen K Bowser; Kristen Farnham; Mark Mangus; Laura Padula; Kathleen Porco; Mary Rozga Journal: J Acad Nutr Diet Date: 2020-06-19 Impact factor: 5.234
Authors: Perry S Brown; Dixie Durham; Rick D Tivis; Shannon Stamper; Cleary Waldren; Sarah E Toevs; Barbara Gordon; Tiffany A Robb Journal: Front Public Health Date: 2018-11-26
Authors: Moriah P Bellissimo; Emory Hsu; Li Hao; Kirk Easley; Greg S Martin; Thomas R Ziegler; Jessica A Alvarez Journal: J Clin Transl Endocrinol Date: 2021-06-06
Authors: Andrea Granados; Elizabeth A Beach; Andrew J Christiansen; Bruce W Patterson; Michael Wallendorf; Ana María Arbeláez Journal: J Cyst Fibros Date: 2021-06-26 Impact factor: 5.527